MICHAEL PEROSKI: Open Payments
NPI 1689092454 · DUBUQUE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 39 payments from 13 companies in 2025. Trend: 2023 $416 · 2024 $508 · 2025 $594
Food & beverage: $594
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $141 |
| Teva Pharmaceuticals USA, Inc. | 6 | $110 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| LivaNova USA, Inc. | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| E.R. Squibb & Sons, L.L.C. | 3 | $43 |
| Alkermes, Inc. | 2 | $38 |
| Corium, LLC | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: VRAYLAR, AUSTEDO XR, Sunosi, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, COBENFY, ARISTADA, UZEDY, ABILIFY ASIMTUFII.
Industry payments across IA — which companies pay providers there.
